Members of ACME Portable are always striving to innovate and better the world. After an extensive amount of research, we have finished developing a revolutionary technology and are on the verge of releasing it to the public. So, what exactly is this ground-breaking technology?
As some of you may know, ischemic heart disease (IHD) is the most common type of heart disease and cause of heart attacks. The disease is caused by plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and reduces blood flow to the heart. While the symptoms and signs of coronary artery disease are noted in the advanced state of the disease, most individuals with coronary artery disease show no evidence of disease for decades. As the disease progresses and spreads, the first onset of symptoms, generally a "sudden" heart attack, finally and unfortunately arises.
We wanted to find a solution to this problem.
In the past, undergoing diagnosis for IHD required invasive tests and procedures. Ischemia diagnosis had relatively low sensitivity and specificity of resting ECG. There was possible radiation exposure (MPI / angiography). At ACME, we have built a new technology that would make detecting ischemia non-invasive, accurate, and cost-effective.
Because of the nature of this industry, we have a site dedicated entirely toward the medical industry. To visit our medical site, please click below:
The QED 2000 is a complete 12 Lead Electrocardiograph (ECG) solution with ECG interpretation software. Designed to assist health care professionals in delivering the utmost quality care to patients, the ECG reading can be easily and accurately acquired, analyzed, stored and printed in one touch.